Clinical Trials Browser

Phase 1 × Gliosarcoma × Ipilimumab × Clear all

NCT07134842 2026-04-09

WinGlio-ipi

Phase 1 Recruiting

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT02311920 2023-01-10

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Phase 1 Completed

Gliosarcoma